Saturday, August 23, 2014
Inquirer Daily News

Poll: AIDS and U.S. drugmakers

With Johnson & Johnson's decision not to participate in a program providing cheaper AIDS drugs in poor nations, a public debate has been restarted on the best way to achieve the same goal. Where do you stand?

Poll: AIDS and U.S. drugmakers

With Johnson & Johnson's decision not to participate in a program providing cheaper AIDS drugs in poor nations, a public debate has been restarted on the best way to achieve the same goal. Where do you stand?

Cast your vote now.

Should U.S. drug firms find a way to provide low-cost AIDS drugs to poor nations?
Yes, should be industry-wide effort as good corporate citizens
No, not unless they cover their costs
Yes, but only if government provides a subsidy
No, drug cost should be covered by U.S. foreign aid funds
About this blog

The Inquirer Editorial Board's Say What? opinion blog showcases the work of the editors and writers who produce the newspaper's daily and Sunday opinion pages.

Find out more about The Inquirer's Editorial Board here.

The Inquirer Editorial Board
Also on Philly.com
Stay Connected